Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-006287
Filing Date
2004-06-15
Accepted
2004-06-15 17:10:33
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AAIPHARMA INC. g87794e10vk.htm 10-K 1342507
2 EX-10.20 g87794exv10w20.txt EX-10.20 60781
3 EX-10.21 g87794exv10w21.txt EX-10.21 39323
4 EX-10.22 g87794exv10w22.txt EX-10.22 70263
5 EX-10.23 g87794exv10w23.txt EX-10.23 4705
6 EX-18 g87794exv18.htm EX-18 1641
7 EX-23 g87794exv23.htm EX-23 1106
8 EX-31.1 g87794exv31w1.htm EX-31.1 7663
9 EX-31.2 g87794exv31w2.htm EX-31.2 7833
10 EX-32 g87794exv32.htm EX-32 2816
  Complete submission text file 0000950144-04-006287.txt   1541239
Mailing Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405
Business Address 2320 SCIENTIFIC PARK DRIVE WILMINGTON NC 28405 9102547000
AAIPHARMA INC (Filer) CIK: 0001013243 (see all company filings)

EIN.: 042687849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21185 | Film No.: 04864690
SIC: 8734 Services-Testing Laboratories